 |
PDBsum entry 6yok
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Direct introduction of an alkylsulfonamido group on c-Sites of isomeric dicarba-Closo-Dodecaboranes: the influence of stereochemistry on inhibitory activity against the cancer-Associated carbonic anhydrase IX isoenzyme.
|
 |
|
Authors
|
 |
J.Nekvinda,
M.Kugler,
J.Holub,
S.El anwar,
J.Brynda,
K.Pospíšilová,
Z.RůžIčková,
P.ŘEzáčová,
B.Grüner.
|
 |
|
Ref.
|
 |
Chemistry, 2020,
26,
16541-16553.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Carbonic anhydrase IX (CA IX), a tumor-associated metalloenzyme, represents a
validated target for cancer therapy and diagnostics. Herein, we report the
inhibition properties of isomeric families of
sulfonamidopropyl-dicarba-closo-dodecaboranes group(s) prepared using a new
direct five-step synthesis from the corresponding parent cages. The protocol
offers a reliable solution for synthesis of singly and doubly substituted
dicarba-closo-dodecaboranes with a different geometric position of carbon atoms.
The closo-compounds from the ortho- and meta-series were then degraded to
corresponding 11-vertex dicarba-nido-undecaborate(1-) anions. All compounds show
in vitro enzymatic activity against CA IX in the low nanomolar or subnanomolar
range. This is accompanied by clear isomer dependence of the inhibition constant
(Ki ) and selectivity towards CA IX. Decreasing trends in
Ki and selectivity index (SI ) values are observed with
increasing separation of the cage carbon atoms. Interactions of compounds with
the active sites of CA IX were explored with X-ray crystallography, and eight
high-resolution crystal structures uncovered the structural basis of inhibition
potency and selectivity.
|
 |
|
|
|
|
 |